Freda Lewis-Hall, Angel Investor

Freda Lewis-Hall is an angel investor focused on healthcare and biotechnology. Her investment includes Cheiron, a biotechnology company developing therapies for cancer and other serious diseases. Her investment activity has included a Seed round, where Cheiron raised a total of $8 million. She has participated in supporting an early-stage biotechnology company. Freda previously served as Executive Vice President and Chief Patient Officer at Pfizer. She held senior leadership roles at the pharmaceutical company for more than a year.